Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Savara Inc | Director | Common Stock | 191K | $849K | $4.45 | Dec 14, 2023 | Direct |
Savara Inc | Director | Stock Option (Right to Buy) | 40K | Dec 13, 2022 | Direct | ||
LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 3.33K | Jun 5, 2024 | Direct | ||
Kindred Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | $4.81 | Aug 27, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
(LUMO) | LUMOS PHARMA, INC. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
SVRA | Savara Inc | Dec 14, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
LUMO | LUMOS PHARMA, INC. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
SVRA | Savara Inc | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | Nov 16, 2022 | 1 | $20.1K | 4 | Nov 18, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 25, 2022 | 1 | $27.3K | 4 | Aug 26, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
SVRA | Savara Inc | Dec 14, 2021 | 1 | $0 | 4 | Dec 14, 2021 | Director |
KIN | Kindred Biosciences, Inc. | Aug 27, 2021 | 5 | -$233K | 4 | Aug 30, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 11, 2021 | 1 | $56.4K | 4 | Aug 13, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |